Clinical Trial Update: Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer [Phase 1]

View source ↗

Summary

A phase 1 trial investigating selenium as a treatment in patients undergoing brachytherapy for early-stage prostate cancer (Stage I/II) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED